Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD4+ T Lymphocyte Tumor (T Cell Lymphoma and T Cell Leukemia)”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Early research (Phase 1)Study completedNCT00602693
What this trial is testing

T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Masonic Cancer Center, University of Minnesota 41
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Early research (Phase 1)Ended earlyNCT04219319
What this trial is testing

LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T-cell Lymphoma

Who this might be right for
CD4+ T Lymphocyte Tumor (T Cell Lymphoma and T Cell Leukemia)
The First Affiliated Hospital with Nanjing Medical University 4
Early research (Phase 1)Ended earlyNCT03203369
What this trial is testing

Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Cellectis S.A. 1
Testing effectiveness (Phase 2)Temporarily pausedNCT06761677
What this trial is testing

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Lymphoma Including ENKL
SymBio Pharmaceuticals 43
Early research (Phase 1)UnknownNCT04162340
What this trial is testing

CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies

Who this might be right for
T Cell Lymphoma in RelapseRefractory T-Cell Lymphoma
iCell Gene Therapeutics 12
Early research (Phase 1)Looking for participantsNCT03829540
What this trial is testing

CD4CAR for CD4+ Leukemia and Lymphoma

Who this might be right for
T-cell LymphomaT-cell Leukemia
Huda Salman 20
Early research (Phase 1)Study completedNCT02689453
What this trial is testing

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

Who this might be right for
T-Cell Lymphoma RelapsedAdult T-Cell Leukemia (ATL)Peripheral T-Cell Lymphoma (PTCL)+2 more
National Cancer Institute (NCI) 11
Early research (Phase 1)Looking for participantsNCT03326921
What this trial is testing

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Who this might be right for
Juvenile Myelomonocytic LeukemiaRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Undifferentiated Leukemia+26 more
Fred Hutchinson Cancer Center 24
Early research (Phase 1)Ended earlyNCT00725062
What this trial is testing

Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Masonic Cancer Center, University of Minnesota 3
Early research (Phase 1)Ended earlyNCT04973527
What this trial is testing

LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor

Who this might be right for
T Cell LymphomaT-cell Leukemia
Beijing Boren Hospital 9